P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance. (Q27308938)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance. |
scientific article |
Statements
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance (English)
Ari Hashimoto
Shigeru Hashimoto
Hirokazu Sugino
Ayumu Yoshikawa
Yutaro Otsuka
Yasuhito Onodera
Jin-Min Nam
Chitose Oneyama
Masato Okada
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references